Interim report

INTERIM REPORT January 1 - September 30 1998 * Sales: January 1 - September 30, SEK 35.4 million (compared to SEK 9.1 million for the same period in 1997). * Sales: July 1 - September 30, SEK 12.5 million. (compared to SEK 3.4 million for the same period in 1997). * Operating loss: SEK -41.5 million (compared to SEK -67.5 million for the same period in 1997) (operating loss for the nine months ended September 30, includes nonrecurring revenue from Biora's Japanese partner in an amount of SEK 39.4 million). * Loss after tax: SEK -32.2 million (compared to SEK -53.8 million for the same period in 1997) ® * Biora's principal product, Emdogain , was approved and launched in Japan. TM * Biora's second product, PrefGel , was launched in the Nordic countries, Germany and the United States. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1998/11/05/19981105BIT00410/bit0001.pdf http://www.bit.se/bitonline/1998/11/05/19981105BIT00410/bit0002.doc